Loading clinical trials...
Loading clinical trials...
A Prospective, Randomized Evaluation of Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent) or Travoprost Ophthalmic Solution 0.004%
Conditions
Interventions
iStent
Travoprost
Locations
1
Armenia
S.V. Malayan Ophthalmological Center
Yerevan, Armenia
Start Date
September 1, 2011
Primary Completion Date
January 1, 2017
Completion Date
April 1, 2017
Last Updated
December 18, 2017
NCT06267274
NCT03850782
NCT00804323
NCT04333433
NCT03931317
NCT01444040
Lead Sponsor
Glaukos Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions